Raloxifene neutralizes bone brittleness induced by anti-remodeling treatment and increases fatigue life through non-cell mediated mechanisms. Actual. Osteol. [Internet]. 2024 Jul. 2 [cited 2026 Oct. 11];12(3):169-7. Available from: https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/310